Back to stocks
NSRX

NSRX

Nasus Pharma Ltd.• Healthcare

Institutional holders
9
As of Q3 2026
Total 13F value
$7.8M
Sum of disclosed positions
New positions
1
This quarter
Sold positions
2
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Balyasny Asset Management L.P.

$3.3M898.5K0.00%Unchanged

Cable Car Capital, Lp

$2.3M616.1K0.26%Unchanged

Velan Capital Investment Management Lp

$1.3M359.4K1.27%Unchanged

Hudson Bay Capital Management Lp

$497K134.8K0.00%Unchanged

Bleichroeder Lp

$332K89.8K0.03%Unchanged

Renaissance Technologies

$54K14.6K0.00%+19.7%

Pinnacle Financial Group, Inc.

$36K9.7K0.00%New Position

Morgan Stanley

$4K1.0K0.00%Unchanged

Caitong International Asset Management Co., Ltd

$1540.00%Unchanged

Explore